Cargando…

Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis

This randomised, double‐blind, placebo‐controlled trial assessed the efficacy, safety and tolerability of voriconazole+anidulafungin (combination) or voriconazole+placebo (monotherapy) for invasive aspergillosis (IA; NCT00531479). We present a post hoc analysis of Korean and non‐Korean patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dong‐Gun, Lee, Hye‐Jung, Yan, Jean Li, Lin, Stephen Sheng‐Fong, Aram, Jalal A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003761/ https://www.ncbi.nlm.nih.gov/pubmed/31355956 http://dx.doi.org/10.1111/myc.12972

Ejemplares similares

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Invasive Aspergillosis in the Intensive Care Unit: Beyond the Typical Haematological Patient
por: Meersseman, Wouter
Publicado: (2009)

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
por: Thornton, Christopher, et al.
Publicado: (2012)

Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?
por: Walsh, Thomas J., et al.
Publicado: (2020)

Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases
por: Han, Seung Beom, et al.
Publicado: (2015)

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019)

TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis
por: Bernal-Martínez, L, et al.
Publicado: (2021)

SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis
por: Borroto-Esoda, Katyna, et al.
Publicado: (2017)

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation
por: Cesaro, Simone, et al.
Publicado: (2011)

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis()
por: Denning, David W., et al.
Publicado: (2006)

Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation
por: Urbanowicz, Tomasz, et al.
Publicado: (2016)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole
por: Jacobs, F., et al.
Publicado: (2011)

Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
por: Ghannoum, M., et al.
Publicado: (2018)

Potential antifungal targets based on histones post-translational modifications against invasive aspergillosis
por: Li, Yiman, et al.
Publicado: (2022)

GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis
por: Shaw, Karen Joy
Publicado: (2022)

Molecular epidemiology and antifungal susceptibilities of Aspergillus species isolated from patients with invasive aspergillosis
por: Sarigüzel, Fatma Mutlu, et al.
Publicado: (2023)

Prognosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases in Korea
por: Kwon, Jae-Cheol, et al.
Publicado: (2012)

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
por: Natesan, Suganthini Krishnan, et al.
Publicado: (2016)

PB2589: EFFICACY AND SAFETY OF ABCD IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES
por: Pang, Aiming, et al.
Publicado: (2023)

A Novel Strategy to Identify Haematology Patients at High Risk of Developing Aspergillosis
por: Griffiths, James S., et al.
Publicado: (2021)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression
por: Kasper, Ekkehard M., et al.
Publicado: (2011)

Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis
por: Mittal, Ashwani, et al.
Publicado: (2013)

Genetic Variation in PFKFB3 Impairs Antifungal Immunometabolic Responses and Predisposes to Invasive Pulmonary Aspergillosis
por: Gonçalves, Samuel M., et al.
Publicado: (2021)

Diagnostic performance of mycological tests for invasive pulmonary aspergillosis in non-haematological patients: protocol for a systematic review and meta-analysis
por: Liu, Meilu, et al.
Publicado: (2022)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units
por: Yang, Qianting, et al.
Publicado: (2022)

Are We There Yet? Recent Progress in the Molecular Diagnosis and Novel Antifungal Targeting of Aspergillus fumigatus and Invasive Aspergillosis
por: Steinbach, William J.
Publicado: (2013)

Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options
por: Chen, Danli, et al.
Publicado: (2021)

Antifungal Siderophore Conjugates for Theranostic Applications in Invasive Pulmonary Aspergillosis Using Low-Molecular TAFC Scaffolds
por: Pfister, Joachim, et al.
Publicado: (2021)

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
por: Ostermann, Helmut, et al.
Publicado: (2014)

Invasive Aspergillosis of the Abdominal Aorta with Multiple Peripheral Embolic Lesions
por: Lee, Jae-Hwan, et al.
Publicado: (2017)

Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
por: Kim, Si-Hyun, et al.
Publicado: (2013)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022)

Pediatric Invasive Aspergillosis
por: Wattier, Rachel L., et al.
Publicado: (2016)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Efficacy of Ebselen Against Invasive Aspergillosis in a Murine Model
por: Sakita, Karina Mayumi, et al.
Publicado: (2021)

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study
por: Stull, Katherine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q6jj2rj6lmg5ohsgeueerqhf94